This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by van Amersfoorth, S. C. M.
Right arrow Articles by Mooi, F. R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by van Amersfoorth, S. C. M.
Right arrow Articles by Mooi, F. R.

 Previous Article  |  Next Article 

Journal of Clinical Microbiology, June 2005, p. 2837-2843, Vol. 43, No. 6
0095-1137/05/$08.00+0     doi:10.1128/JCM.43.6.2837-2843.2005
Copyright © 2005, American Society for Microbiology. All Rights Reserved.

Analysis of Bordetella pertussis Populations in European Countries with Different Vaccination Policies

S. C. M. van Amersfoorth,1 L. M. Schouls,1 H. G. J. van der Heide,1 A. Advani,2 H. O. Hallander,2 K. Bondeson,3 C. H. W. von König,4 M. Riffelmann,4 C. Vahrenholz,4 N. Guiso,5 V. Caro,5 E. Njamkepo,5 Q. He,6 J. Mertsola,6 and F. R. Mooi1*

Laboratory for Vaccine Preventable Diseases, National Institute of Public Health and the Environment, Bilthoven, The Netherlands,1 Swedish Institute for Infectious Disease Control, SMI, Solna, Sweden,2 Department of Medical Sciences, Uppsala University, Sweden,3 Institut für Hygiene und Laboratoriumsmedizin, Klinikum Krefeld, Krefeld, Germany,4 Institut Pasteur, Molecular Prevention and Therapy for Human Diseases Unit, FRE-CNRS2899 Paris, France,5 The Pertussis Reference Laboratory, National Public Health Institute and Department of Pediatrics, Turku University, Turku, Finland6

Received 23 September 2004/ Returned for modification 6 November 2004/ Accepted 4 January 2005

Despite the widespread use of pertussis vaccines during the last decades, pertussis has remained an endemic disease with frequent epidemic outbreaks. Currently two types of vaccines are used: whole-cell vaccines (WCVs) and recently developed acellular vaccines (ACVs). The long-term aim of our studies is to assess the effect of different vaccination policies on the population structure of Bordetella pertussis and ultimately on the disease burden in Europe. In the present study, a total of 102 B. pertussis isolates from the period 1998 to 2001 from five European countries (Finland, Sweden, Germany, The Netherlands, and France) were characterized. The isolates were analyzed by typing based on variable number of tandem repeats (VNTR); by sequencing of polymorphic genes encoding the surface proteins pertussis toxin S1 and S3 subunits (ptxA and ptxC), pertactin (prn), and tracheal colonization factor (tcfA); and by fimbrial serotyping. The results reveal a relationship between geographic location and VNTR types, the frequency of the ptxC alleles, and serotypes. We have not observed a relationship between the strain characteristics we studied and vaccination programs. Our results provide a baseline which can be used to reveal changes in the B. pertussis population in Europe in the coming years.

* Corresponding author. Mailing address: Laboratory for Vaccine Preventable Diseases. National Institute of Public Health and the Environment, Anthonie van Leeuwenhoeklaan 9, P.O. Box 1, 3720 BA Bilthoven, The Netherlands. Phone: 31-30-274.3091. Fax: 31-30-274.4449. E-mail: fr.mooi{at}rivm.nl.

Journal of Clinical Microbiology, June 2005, p. 2837-2843, Vol. 43, No. 6
0095-1137/05/$08.00+0     doi:10.1128/JCM.43.6.2837-2843.2005
Copyright © 2005, American Society for Microbiology. All Rights Reserved.



This article has been cited by other articles:

  • Litt, D. J., Neal, S. E., Fry, N. K. (2009). Changes in Genetic Diversity of the Bordetella pertussis Population in the United Kingdom between 1920 and 2006 Reflect Vaccination Coverage and Emergence of a Single Dominant Clonal Type. J. Clin. Microbiol. 47: 680-688 [Abstract] [Full Text]  
  • Hallander, H., Advani, A., Riffelmann, M., von Konig, C. H. W., Caro, V., Guiso, N., Mooi, F. R., Gzyl, A., Kaltoft, M. S., Fry, N. K., Mertsola, J., He, Q. (2007). Bordetella pertussis Strains Circulating in Europe in 1999 to 2004 as Determined by Pulsed-Field Gel Electrophoresis. J. Clin. Microbiol. 45: 3257-3262 [Abstract] [Full Text]  
  • Borisova, O., Kombarova, S. Y., Zakharova, N. S., van Gent, M., Aleshkin, V. A., Mazurova, I., Mooi, F. R. (2007). Antigenic Divergence between Bordetella pertussis Clinical Isolates from Moscow, Russia, and Vaccine Strains. CVI 14: 234-238 [Abstract] [Full Text]  
  • Yao, S.-M., Lin, Y.-C., Chou, C.-Y., Chen, Y.-Y., Hsiao, M.-J., Chen, H.-Y., Yan, J.-J., Su, H.-P., Li, S.-Y. (2005). Antigenic Divergence of Bordetella pertussis Isolates in Taiwan. J. Clin. Microbiol. 43: 5457-5461 [Abstract] [Full Text]  


Copyright © 2009 by the American Society for Microbiology.   For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»